Capping Prescription Costs Act of 2021

Bill 117 hr 6228, also known as the Capping Prescription Costs Act of 2021, aims to address the rising costs of prescription medications in the United States. The bill proposes to implement a cap on out-of-pocket expenses for prescription drugs for individuals with private insurance plans.

Under the provisions of the bill, individuals with private insurance plans would not be required to pay more than a certain amount for their prescription medications each year. This cap would provide relief for individuals who struggle to afford necessary medications due to high costs.

The bill also includes measures to increase transparency in drug pricing, requiring pharmaceutical companies to disclose the costs associated with producing and marketing their medications. This transparency is intended to help consumers better understand why prescription drug prices are so high and advocate for more affordable options. Additionally, the Capping Prescription Costs Act of 2021 includes provisions to incentivize the development of generic and biosimilar medications, which are often more affordable alternatives to brand-name drugs. By promoting competition in the pharmaceutical industry, the bill aims to drive down prices and increase access to essential medications for all Americans. Overall, Bill 117 hr 6228 seeks to address the issue of skyrocketing prescription drug costs in the United States by implementing a cap on out-of-pocket expenses, increasing transparency in drug pricing, and promoting the development of more affordable generic and biosimilar medications.